AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push - Reuters
AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
All Coverage
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxNdHUwZ3V2VWJfMjNDSjJEV0NkdHJBZTQ1dFQ0Y1FjdGY1NGsxZFdMbXo1N01Vei05R3dGZTN5MEFlcGJZc3Rmajh0dkZacmNCM2ZUZTVYMTM3TlZTVXNNOWRCVXg4dVkwRnBIUU1yT19ObnhJbW42eXU0OU1tNHgtQmZsZS1SR2RjMUJBanBLX3hCWFBIOS1XRDFGOTgzdW9kaHdzREN1dw?oc=5" target="_blank">AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Bayer gets €3 billion in Apollo deal for contraceptives unit - Reuters
Bayer gets €3 billion in Apollo deal for contraceptives unit Reuters
July 10, 2026 at 06:33 AMAI chip startup SambaNova valued at $11 billion in $1 billion funding round - Reuters
AI chip startup SambaNova valued at $11 billion in $1 billion funding round Reuters
July 8, 2026 at 10:37 AMAI startup Reflection signs over $1 billion computing deal with Nebius - Reuters
AI startup Reflection signs over $1 billion computing deal with Nebius Reuters
July 14, 2026 at 11:15 AMWarburg Pincus nears $7 billion deal for PANTHERx Rare, WSJ reports - Reuters
Warburg Pincus nears $7 billion deal for PANTHERx Rare, WSJ reports Reuters
July 10, 2026 at 05:35 PMAstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports - Reuters
AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports Reuters
July 8, 2026 at 06:34 PMIndia's Dr Reddy's delays semaglutide supply, loses $678 mln in market value - Reuters
India's Dr Reddy's delays semaglutide supply, loses $678 mln in market value Reuters
July 9, 2026 at 04:54 AM